★ Sign in to follow
JT

Joakim Tedroff

Board Director
Membre du Conseil
SE·Finansinspektionen
IRLAB Therapeutics AB
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
10
Company
1
▲ Purchases (3 ops.)
€88k
▼ Sales (0 ops.)
—

Latest filing published 01 Jul 2026 for IRLAB Therapeutics AB, €431k.

Filing timeline

BuySale
Joakim Tedroff

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Joakim Tedroff: trading record in brief

All filings by Joakim Tedroff on record concern IRLAB Therapeutics AB, in the capacity of board member. The record holds 10 filings, for trades running from 10 July 2019 to 1 July 2026.

The open-market record is one-sided, with 3 purchases worth €88k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Half of the purchases are above €29k and half below.

The record was last updated on 1 July 2026 with a transaction (€431k) in IRLAB Therapeutics AB. The latest purchase dates back some time: it was published 345 days ago, on 28 November 2025. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Joakim Tedroff

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total
  • ●
    Joakim Tedroff
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Therapeutics AB
    5M SEK0FI-SE
    4,016,742 shares@ SEK 1.2062.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-fd654d5a64a63337a524
  • ●
    Joakim Tedroff
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Therapeutics AB
    667,010 SEK0FI-SE
    555,842 shares@ SEK 1.208.6% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:csv-042e9dab302a546e5d34
  • ▲
    Joakim Tedroff
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Therapeutics AB
    500,000 SEK8FI-SE
    250,000 shares@ SEK 2.000.21% mcap6.5% of flowAktieISIN SE0012675361FI:A003U250-1
    Canonical exit: 26 Feb 2026 (T+90)
  • ▲
    Joakim Tedroff
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Therapeutics AB
    140,000 SEK7FI-SE
    70,000 shares@ SEK 2.000.058% mcap1.8% of flowAktieISIN SE0012675361FI:A003U002-1
    Canonical exit: 18 Feb 2026 (T+90)
  • ●
    Joakim Tedroff
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Therapeutics AB
    1M SEK0FI-SE
    357,327 shares@ SEK 3.5015.9% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q791-1
  • ●
    Joakim Tedroff
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Therapeutics AB
    406,686 SEK0FI-SE
    116,196 shares@ SEK 3.505.2% of flowBTA (betald tecknad aktie)ISIN SE0025400179FI:A003Q787-1
  • ▲
    Joakim Tedroff
    CMOExecutivesIRLAB Therapeutics AB
    310,500 SEK0FI-SE
    11,500 shares@ SEK 27.004.1% of flowBTA (betald tecknad aktie)ISIN SE0013748324FI:csv-9b2824bed5aa3d17d4e7
    Canonical exit: 25 May 2020 (T+90)
  • ●
    Joakim Tedroff
    CMOExecutivesIRLAB Therapeutics AB
    3M SEK0FI-SE
    31,299 shares@ SEK 92.18AktieISIN SE0012675379FI:csv-23a399164443e73d1d73

8 of 8 declarations

Related entities

No related entities found.